Showing 1 - 3 results of 3 for search 'Brendan D Looyenga', query time: 0.07s Refine Results
  1. 1
    Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway.

    Cytokine receptor-like factor 1 (CRLF1) protects against 6-hydroxydopamine toxicity independent of the gp130/JAK signaling pathway. by Brendan D Looyenga, James Resau, Jeffrey P MacKeigan

    Published 2013-01-01
    Get full text
    Article
  2. 2
    Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway.

    Correction: Cytokine Receptor-Like Factor 1 () Protects against 6-Hydroxydopamine Toxicity Independent of the gp130/JAK Signaling Pathway. by Brendan D. Looyenga, James Resau, Jeffrey P. MacKeigan

    Published 2014-01-01
    Get full text
    Article
  3. 3
    A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels

    A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels by Nathan J. Lanning, Brendan D. Looyenga, Audra L. Kauffman, Natalie M. Niemi, Jessica Sudderth, Ralph J. DeBerardinis, Jeffrey P. MacKeigan

    Published 2014-05-01
    Get full text
    Article

Search Tools: